News
Proud to Join the SME Climate Hub: Committing to A...
We’re thrilled to join the SME Climate Hub community, committing to halve our emissions by 2030. Together, we're taking authentic action towards ...
Adoption of statistical methods for recurrent even...
Quentin Pilard (Senior Biostatistician) and David Herman (Biostatistician) are presenting our poster entitled “Analyzing Recurrent Events in Mult...
Gender equality index 2023
The French law on the freedom to choose one’s professional future of September 5, 2018 makes equal pay for men and women an obligation of result...
Machine learning achieves promising performance in...
Delays in the diagnosis of rare genetic conditions such as acid sphingomyelinase deficiency (ASMD) highlight the necessity for diagnostic...
Constances cohort and Quinten Health partner to de...
Paris, February 28th, 2024 – Clinical trial results can now be projected into real-world outcomes and care of chronic patients optimized by combi...
The “Digital Twin in Healthcare” Webin...
Alexandre Templier will participate at the “Le jumeau numérique en santé” webinar, organized by POC Media, a French news service specialized in...
The Open-Source Revolution of AliBERT in French Bi...
Developed by Quinten in 2022, AliBERT is a specialized model focusing on the French biomedical language. One version has been released as an open-s...
Quinten Health joins the partners of the AGORiA SA...
As an expert in data analysis, modeling, and advanced simulation for health decision support, we will contribute to the identification of new use...
Les Grandes Tendances e-santé 2024
Explore the Future of digital health (E-santé): Engage with industry leaders at Station F in Paris and delve into the digital health...
Enhancing Patient-Centered Decision-Making: Quinte...
In efforts to push for the use of registry data to support patient-centered decision-making in regulatory and health technology assessment (HTA) pr...
AIOLOS project’s Minimum Viable Product (MVP) sh...
We had the occasion to highlight the collective initiatives of the AIOLOS project with an informative poster at ISPOR Europe 2023. This poster aims...
Nordic Life Science Days 2023: Quinten Health sele...
As announced in October, Quinten Health will be participating in the inaugural 'Life Sciences in the Nordic Countries' mission, launched by Bpifran...
AI for Health Summit 2023 : gather and connect act...
For our inaugural attendance at the the AI for Health Summit 2023, our executive team is preparing to showcase our expertise during this exclusive ...
Heading to ISPOR 2023, a deepdive in health econom...
Quinten Health joins ISPOR Europe 2023, the leading European conference for health economics and outcomes research (HEOR) in Copenhagen.We're...
AliBERT achieves it first successful application i...
A successful proof-of-concept for AliBERT, the first French-language model specialized in the biomedical field. In partnership with a major French ...
A machine learning algorithm to identify persons a...
Gaucher disease is a rare inherited lysosomal storage disorder (LSD) which mainly leads to hepatosplenomegaly, anemia, thrombocytopenia, bone lesio...
Quinten Health to attend the first “Life Sci...
Quinten Health is delighted to announce its participation to the first “Life Sciences in the Nordic countries ” mission launched by Bpifrance ...
A promising algorithm for early diagnosis and inte...
A promising algorithm for early diagnosis of Acid Sphingomyelinase Deficiency (ASMD) in patients with unexplained Interstitial Lung Disease...
Alexandre Templier will speak at the Real-World Ev...
Quinten Health will be at the Real-World Evidence and Market Access Conference in Frankfurt, Germany.Alexandre Templier (President)will attend as...
Quinten Health at BiotechX Europe 2023 for the sec...
Quinten Health will be at BioTechX Europe in Basel, Switzerland.For the second year running, Quinten Health will be present at BioTechX! It's an...
Unicancer and Quinten Health partner to develop a ...
Clinical trials in oncology can now be de-risked and their results projected into long term real-world outcomes by combining Unicancer's clinical...